This hybrid system measures hemoglobin and oxygen saturation in real-time, highlighting advances in non-invasive monitoring.
This paper presents a CMOS-based hybrid system capable of noninvasively quantifying the total hemoglobin (tHb), the oxygen saturation (SpO2), and the heart rate (HR) by utilizing five-wavelength (670, 770, 810, 850, and 950 nm) photoplethysmography. Conventional pulse oximeters are limited to the measurements of SpO2 and heart rate, therefore hindering the real-time estimation of tHb that is clinically essential for monitoring anemia, chronic diseases, and postoperative recovery. Therefore, the proposed hybrid system enables us to distinguish between the concentrations of oxygenated (HbO2) and deoxygenated hemoglobin (Hb) by using the absorption characteristics of five wavelengths from the visible to near-infrared range. This CMOS hybrid mixed-signal architecture includes a light emitting diode (LED) driver as a transmitter and an optoelectronic receiver with on-chip avalanche photodiodes, followed by a field-programmable gate array (FPGA) for a real-time signal processing pipeline. The proposed hybrid system, validated through post-layout simulations and algorithmic verification, achieves high precision with ±0.3 g/dL accuracy for tHb and ±1.5% for SpO2, while the heart rate is extracted via 1024-point Fast Fourier Transform (FFT) with an error below ±0.2%. These results demonstrate the potential of a CMOS-based hybrid system as a feasible solution to achieve real-time, low-power, and high-accuracy analysis of bio-signals for clinical and home-use applications.
No takes yet. Share an insight, caveat, or question.
Park et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: